Sign in

NCT06397677Recruiting

Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease

Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease (MOUNTAIN)

Source: ClinicalTrials.gov · Last updated 3 May 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

A study to identify patients with Rheumatoid Arthritis - Associated Interstitial Lung Disease (RA-ILD) that are at the highest risk for progression. The goal of the investigators is to recruit a group of patients with RA-ILD and collect information to help us understand more about disease progression. The investigators will do this using a combination of clinical, radiologic, and biologic features.

Status (registry)
Recruiting
Study type
Observational
Enrollment
450 (estimated)
First submitted
1 Dec 2023
Start date
22 Jan 2024
Primary completion date
Jan 2029
Lead sponsor
University of Colorado, Denver
NCT number
NCT06397677

What you commit to

  • Study type: Observational
  • Planned participants: 450
  • From 22 Jan 2024 to the primary completion date, Jan 2029
  • 4 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Prior medication treatment specifically for RA-ILD

Other

  • Inability to give informed consent
  • Pregnant women

Who the study is looking for

  • Multidisciplinary diagnosis of RA-ILD based on the 2010 American College of Rheumatology criteria
  • 18 years of age or older

Age in the registry: 18 years to 90 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (4)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
University of Michigan
Coordinator of this site? Confirm its status
Ann ArborUnited StatesRecruiting
University of Colorado Denver
Coordinator of this site? Confirm its status
AuroraUnited StatesRecruiting
University of Kansas
Coordinator of this site? Confirm its status
Kansas CityUnited StatesRecruiting
University of California San Francisco
Coordinator of this site? Confirm its status
San FranciscoUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.